Article

FFB funds nearly $3 million to research

Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fight Blindness.

 

Columbia, MD-Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fighting Blindness.

The foundation’s Scientific Advisory Board completed its annual grants review process, leading to the allocation of seven new $300,000, three-year grants which total $2.1 million.

The grants will focus on developing cross-cutting gene therapies, identifying new disease-causing gene mutations, and advancing potential treatments for dry age-related macular degeration.

Another $800,000 was awarded to two research efforts at the University of California, Berkley, which focus on optogenetic approaches to treat blinding inherited retinal diseases.

“Retinal diseases together affect more than 10 million Americans, and with an aging population, this number is growing,” said Stephen Rose, PhD, the foundation’s chief research officer. “The progress being made in research right now is remarkable; however, there is still a long way to go to secure the resources to significantly expand the portfolio of trials across the spectrum of retinal diseases.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.